Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter

CardioVascular and Interventional Radiology

Volumn 40, Issue 10, 2017, Pages 1535-1544

  Tepe, Gunnar ^a   Gögebakan, Özlem ^b   Redlich, Ulf ^c   Tautenhahn, Jörg ^c   Ricke, Jens ^d   Halloul, Zuhir ^d   Meyer, Dirk Roelfs ^e   Waliszewski, Matthias ^f   Schnorr, Beatrix ^g   Zeller, Thomas ^h   Müller Hülsbeck, Stefan ⁱ   Ott, Ilka ^j   Albrecht, Thomas ^b  

^a Klinikum Rosenheim   (Germany)

^b VIVANTES HOSPITAL   (Germany)

^c Klinikum Magdeburg   (Germany)

^d UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^e St Hubertus Hospital   (Germany)

^f B Braun Melsungen AG   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

ⁱ Diakonissenanstalt zu Flensburg   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Drug coated balloon catheter; Femoro popliteal lesions; Peripheral artery occlusive disease

Indexed keywords

PACLITAXEL; TUBULIN MODULATOR;

AGED; ARTICLE; BALLOON CATHETER; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; DRUG-ELUTING BALLOON CATHETER; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANGIOGRAPHY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFECT; FEMORAL ARTERY; GERMANY; MULTICENTER STUDY; PATHOPHYSIOLOGY; POPLITEAL ARTERY; PROCEDURES; PROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; FEMALE; FEMORAL ARTERY; GERMANY; HUMANS; MALE; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 85025163131     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-017-1713-2     Document Type: Article

References (18)

1. Diehm C, Allenberg JR, Pittrow D, et al. German epidemiological trial on ankle brachial index study group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–61.
2. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.
3. Schillinger M, Minar E. Claudication: treatment options for femoropopliteal disease. Prog Cardiovasc Dis. 2011;54(1):41–6.
4. Albrecht T, Speck U, Baier C, et al. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol. 2007;42(8):579–85.
5. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–99.
6. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118(13):1358–65.
7. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5(6):831–40.
8. Laird JR, Schneider PA, Tepe G, et al. IN.PACT SFA trial investigators. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66(21):2329–38.
9. Rosenfield K, Jaff MR, White CJ, et al. LEVANT 2 investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373(2):145-53. Cardiol. 2015;66(21):2329-38.
10. Katsanos K, Kitrou P, Spiliopoulos S, Diamantopoulos A, Karnabatidis D. Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016;23(6):851–63.
11. Giacoppo D, Cassese S, Harada Y, Colleran R, Michel J, Fusaro M, Kastrati A, Byrne RA. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials. JACC Cardiovasc Interv. 2016;9(16):1731–42.
12. Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23(2):356–70.
13. Byrne RA, Joner M, Alfonso F, Kastrati A. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol. 2014;11(1):13–23.
14. Scheinert D, Duda S, Zeller T, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7(1):10–9.
15. Schroeder H, Meyer DR, Lux B, et al. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study. Catheter Cardiovasc Interv. 2015;86(2):278–86.
16. Scheinert D, Schulte KL, Zeller T, et al. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther. 2015;22(1):14–21.
17. Jia X, Zhang J, Zhuang B, et al. Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the acoart I trial. JACC Cardiovasc Interv. 2016;9(18):1941–9.
18. Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv. 2015;8(1 Pt A):102–8.